Thrombomodulin Is a Cofactor for Thrombin Degradation of Recombinant Single-Chain Urokinase Plasminogen Activator "In Vitro" and in a Perfused Rabbit Heart Model

Summary

Thrombin cleaves single-chain urokinase-type plasminogen activator (scu-PA) to a two-chain derivative (tcu-PA) fibrinolyti-cally inactive. This reaction was accelerated in vitro by purified rabbit lung thrombomodulin in equimolar complex with thrombin. Polyclonal antibodies to rabbit thrombomodulin prevented this effect.

We also observed that heparin and other sulfated polysaccharides had an accelerating effect on thrombin cleavage of recombinant scu-PA. Their effect was concentration-dependent and then reversed at high levels. The effect of heparin and heparan sulfate was independent and synergic with respect to thrombomodulin. All observations except the effect of heparin, could be confirmed in a Langendorff isolated rabbit heart model. From competition experiments carried out with scu-PA derivatives and mutants, we postulate that the amino-terminal sequence of rscu-PA, containing the epidermal growth factor (EGF)-like and the kringle domains is involved in the cofactor effect of thrombomodulin on scu-PA inactivation by thrombin. We conclude that a regulatory mechanism of scu-PA inactivation is present at the cell surface.

• References

• 1 Nolan C, Hall LS, Barlow GH, Tribby I. I. Plasminogen activator from human embryonic kidney cell cultures evidence for a proactivator. Biochem Biophys Acta 1977; 496: 384-400
• 2 Husain SS, Gurewich V, Lipinski B. Purification and partial characterization of a single-chain high-molecular weight form of urokinase from human urine. Arch Biochem Biophys 1983; 22: 31-38
• 3 Collen D. Report of the Subcommittee on Fibrinolysis. Thromb Haemostas 1985; 54: 893
• 4 Stump DC, Thienpont M, Collen D. Urokinase-related proteins in human urine. J Biol Chem 1986; 261: 1267-1273
• 5 Wun TC, Schleiuning WD, Reich E. Isolation and characterization of urokinase from human plasma. J Biol Chem 1982; 257: 3276-3283
• 6 Wijngaards G, Rijken DC, Van Wezel AL, Groeneveld E, Van Der Velden CAM. Characterization and fibrin-binding properties of different molecular forms of pro-urokinase from a monkey kidney cell culture. Thromb Res 1986; 42: 749-760
• 7 Gunzler WA, Steffans GJ, Otting F, Buse G, Flohe L. Structural relationship between high and low molecular mass urokinase. Hoppe-Seyler’s Physiol Chem 1982; 363: 133-141
• 8 Verde P, Stoppelli MP, Galeffi P, Dinnocera P, Blasi F. Identification and primary sequence of an unspliced human urokinase poly (A) + RNA. Proc Natl Acad Sci USA 1984; 81: 4727-4731
• 9 Kasai S, Arimura H, Nishida M, Suyama T. Primary structure of single-chain pro-urokinase. J Biol Chem 1985; 260: 12382-12389
• 10 Holmes WE, Pennica D, Blaber M, Rey MW, Gunzler WA, Steffans GJ, Heynecher HI. Cloning and expression of the gene for prourokinase in Escherichia coli . Biotechnology 1985; 3: 923-929
• 11 Zamarron C, Lijnen HR, Van Hoef B, Collen D. Biological and thrombolytic properties of proenzyme and active forms of human urokinase. I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology. Thromb Haemostas 1984; 52: 19-23
• 12 Gurewich V, Pannell R, Louie S, Kelley P, Suddith RL, Greenlee R. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species. J Clin Invest 1984; 73: 1731-1739
• 13 Husain SS, Gurewich V, Lipinski B. Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine. Arch Biochem Biophys 1983; 220: 6231-6238
• 14 Eaton DL, Scott RW, Baker JB. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin. J Biol Chem 1984; 259: 6241-6247
• 15 Ichinose A, Fujikawa K, Suyama T. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem 1986; 261: 3486-3489
• 16 Gurewich V, Pannell R. Inactivation of single-chain urokinase (prourokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experiments. Blood 1987; 69: 769-772
• 17 Conforti G, Loskutoff DF. Plasmin and thrombin modulate plasminogen activation by fibro-sarcoma cells. Thromb Haemostas 1985; 54: 171 (Abstr)
• 18 Lijnen HR, Van Hoef B, Collen D. Activation with plasmin of two-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin. Eur J Biochem 1987; 169: 359-364
• 19 De Munk GAW, Groeneveld D, Rijken DC. Acceleration of the thrombin inactivation of single-chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin. Fibrinolysis 1990; 4: 161 (Abstr)
• 20 Molinari A, Cauet G, Valenti R, Giorgetti C, Lansen J. Effect of various glycosaminoglycans and thrombomodulin on thrombin-mediated conversion of single-chain to two-chain urokinase-type plasminogen activator. Fibrinolysis 1990; 4: 34 (Abstr)
• 21 Orsini G, Brandazza A, Sarmientos P, Molinari A, Lansen J, Cauet G. Efficient renaturation and fibrinolytic properties of pro-urokinase and deletion mutant expressed in E. coli as inclusion bodies. Eur J Biochem 1991; 195: 691-697
• 22 Molinari A, Giorgetti C, Bonomini L, Gerna M, Lansen J, Gurewich V. Differential detection of single-chain urokinase-type plasminogen activator and two-chain urokinase-type plasminogen activator in human and monkey plasma. Fibrinolysis. 1992 in press
• 23 Laemmly UK. Cleavage of structural proteins during assembly of the head of bacteriophage T. Nature 1970; 227: 680
• 24 Lijnen HR, Zamarron C, Blaber M, Winkler ME, Collen D. Activation of plasminogen by pro-urokinase. I. Mechanism. J Biol Chem 1986; 261: 1253-1258
• 25 Owen WG, Esmon CT, Jackson CM. The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin. J Biol Chem 1974; 249: 594-605
• 26 Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-864
• 27 Dorsey TE, McDonald PW, Roels OA. A heated biotinfolin protein assay which gives equal absorbance with different proteins. Anal Biochem 1977; 78: 156-164
• 28 Esmon CT, Owen W. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249-2252
• 29 Lundblad RL, Kingdon HS, Mann KG. Thrombin. In: Methods in Enzymology, Vol. 45: Proteolytic Enzymes. Lorand L. (ed). Academic Press; New York: 1976. pp 156-176
• 30 Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 1982; 256: 7944-7947
• 31 Andrade-Gordon P, Stricklands S. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen. Biochemistry 1986; 25: 4033-4040
• 32 Watahiki Y, Scully MF, Ellis V, Kakkar VV. Influence of heparin and various glycosaminoglycans on activation of single chain urokinasetype plasminogen activtor (scu-PA) by plasmin. Fibrinolysis 1989; 3: 31-35
• 33 Esmon NL. Thrombomodulin. Semin Thromb Hemostas 1987; 13: 454-463
• 34 Pepper MS, Vassalli JD, Montesano R, Orci L. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 1987; 105: 2535-2541